PETMRI in oncology
Combined positron emission tomography/ magnetic resonance imaging (PETMRI) has received heightened interest recently with the introduction of commercially available systems having full body imaging capability. PET imaging with radiolabelled tracers, the most widely used being F18-deoxyglucose (FDG), allows direct probing of metabolism with exquisite sensitivity, demonstrating pathophysiological change before any structural change becomes apparent. With […]
Sofia Michopouolou, David Brown, Simon Wan
University College London Hospitals NHS Foundation Trust